These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11915890)

  • 1. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Feeman W
    Circulation; 2002 Mar; 105(12):e71. PubMed ID: 11915890
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Genazzani AR
    Circulation; 2002 Mar; 105(12):e71. PubMed ID: 11914267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormonal treatment for menopause and arterial risk].
    Gueyffier F; Cornu C
    Rev Prat; 2005 Feb; 55(4):383-8. PubMed ID: 15828616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone replacement therapy in menopause and cardiovascular disease--one more time].
    Os I; Tonstad S
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1808-10. PubMed ID: 12362695
    [No Abstract]   [Full Text] [Related]  

  • 5. Hormone therapy and smoking.
    Andrews C
    J Gend Specif Med; 2000; 3(5):66-7. PubMed ID: 11253259
    [No Abstract]   [Full Text] [Related]  

  • 6. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hormone replacement therapy in menopause and cardiovascular disease].
    Pedersen AT; Skouby SO; Jespersen J; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3973-4. PubMed ID: 12212481
    [No Abstract]   [Full Text] [Related]  

  • 8. Statement on results of the HERS II trial on hormone replacement therapy.
    American College of Obstetricians and Gynecologists
    Ginecol Obstet Mex; 2002 Aug; 70():406-8. PubMed ID: 12448046
    [No Abstract]   [Full Text] [Related]  

  • 9. Hormone replacement therapy. Current controversies.
    Burkman RT
    Minerva Ginecol; 2003 Apr; 55(2):107-16. PubMed ID: 12711997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone therapy during menopause and risk of cardiovascular disease].
    Pedersen AT; Ottesen BS
    Ugeskr Laeger; 2002 Apr; 164(18):2414. PubMed ID: 12024849
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.
    Shah NR
    Cancer; 2003 Oct; 98(7):1552-3; author reply 1553. PubMed ID: 14508845
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy--is there a place for its use in neurology?
    Vuković V; Lovrencić-Huzjan A; Solter VV; Dordević V; Demarin V
    Coll Antropol; 2003 Jun; 27(1):413-24. PubMed ID: 12974172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone therapy and cardiovascular disease after menopause. Myths and realities].
    Skouby SO
    Ugeskr Laeger; 2003 Oct; 165(41):3907. PubMed ID: 14579549
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
    Wenger NK; Geiger MJ
    Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation.
    Klein S; Burke LE; Bray GA; Blair S; Allison DB; Pi-Sunyer X; Hong Y; Eckel RH;
    Circulation; 2004 Nov; 110(18):2952-67. PubMed ID: 15509809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Questioning HRT].
    Letonturier P
    Presse Med; 2002 Aug; 31(27):1253-4. PubMed ID: 12238269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.